Effect of Escitalopram vs. Reboxetine on Gastro-intestinal Sensitivity of Patients With Major Depressive Disorder

Clinical trial NCT00209807 · UNKNOWN

Trial details

NCT number: NCT00209807
Sponsor: Hospital Universitari Vall d'Hebron Research Institute
Status: UNKNOWN
Phase: Phase 4
Study type: INTERVENTIONAL

Major Depression Pain Abdominal Pain

Start date: 2005-09-01
Primary completion: 2009-06-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.